Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

CVS, Walmart Fall as Ohio Jury Rules Them Guilty in Opioid Crisis

Published 11/24/2021, 04:52 AM
Updated 11/24/2021, 04:55 AM
© Reuters.

By Dhirendra Tripathi

Investing.com – Shares of CVS Health (NYSE:CVS) and Walmart (NYSE:WMT) fell 0.6% and 0.4% respectively in Wednesday’s premarket trading a day after a federal jury in Cleveland, Ohio, ruled that their pharmacies were complicit in the opioid epidemic.

Walgreens (NASDAQ:WBA) was also found guilty in the case. The stock closed 0.3% lower in after-hours trading.

Attorneys for Lake and Trumbull counties argued the chains didn’t do enough to stop pain pills from flooding the local markets or to stop false prescriptions from being filled. The counties argued the pharmacy companies’ lack of effort in containing the crisis created public nuisance that cost each about $1 billion in law-enforcement, social-services and court expenses. Public-nuisance laws vary by state, which makes it harder to view the verdict as any kind of precedent for other, similar cases in process elsewhere..

The companies pleaded innocence saying they tried to stop the illegal diversion of pills and that they complied with all procedures mandated by the regulators.

Opioids have taken an increasing toll on U.S. lives in an epidemic that spans over 20 years.

Treatments initially intended for alleviating the suffering of cancer patients were gradually dispensed to patients with a much broader range of ailments. The prescriptions became more frequent, the dosage higher and illegal usage and supply blossomed. 

According to federal figures, the country lost nearly half a million people to overdoses of prescription and illegal opioids between 1999 and 2019. The incidence of overdoses has risen during the pandemic, with fentanyl and other opioids accounting for more than 70% of the 100,000 deaths in the 12 months through April.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Cases against pharmacies, distributors of medicines and drugs and pharmaceutical companies are ongoing in various courts in the country.

Four months ago, Johnson & Johnson (NYSE:JNJ) and distributors including McKesson (NYSE:MCK), Cardinal Health (NYSE:CAH) and AmerisourceBergen (NYSE:ABC) agreed to pay $26 billion over 18 years in a settlement with around 40 states in cases that accused them of fuelling the opioid crisis.

 

 

Latest comments

What about the Sackler family of Purdue Pharma and Mundipharma who largely got away with murder? Quite amazing that none of these family members were not charged criminally! Outrageous!
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.